GeneMatrix Inc (109820) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.13x

GeneMatrix Inc (109820) has a Cash Flow Reinvestment Rate of 0.13x as of September 2025, reinvesting ₩63.17 Million (capex ₩23.65 Million plus investments ₩-39.52 Million) from operating cash flow of ₩500.19 Million. Check earnings quality score of GeneMatrix Inc to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.13x
(Capex + Investments) / Operating CF

Total Reinvested

₩63.17 Million
Capex + Investments

Operating Cash Flow

₩500.19 Million
KRW

Capital Expenditures

₩23.65 Million
KRW

GeneMatrix Inc Cash Flow Reinvestment Rate (2020–2021)

Historical reinvestment intensity for GeneMatrix Inc across 2 annual periods. Explore GeneMatrix Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for GeneMatrix Inc (2020–2021)

Year-by-year capital reinvestment analysis for GeneMatrix Inc. For live market cap and broader valuation context, see GeneMatrix Inc market capitalisation.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2021 0.31x ₩1.04 Billion ₩3.37 Billion ₩258.22 Million ▼ -15.2%
2020 0.36x ₩1.64 Billion ₩4.51 Billion ₩366.56 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow